Mechanism of Action of Ticagrelor
Introduction Ticagrelor is an oral antiplatelet agent used in the management of acute coronary syndrome (ACS) and for secondary prevention of thrombotic events. It directly and reversibly inhibits the P2Y₁₂ receptor on platelets, thereby preventing ADP-induced platelet aggregation. Unlike thienopyridines like clopidogrel, it does not require metabolic activation, leading to a faster and more predictable … Read more